Rhythm Pharma director awarded RSUs and options
RHYTHM PHARMACEUTICALS director Lynn A. Tetreault received new equity awards and exercised existing units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
RHYTHM PHARMACEUTICALS director Lynn A. Tetreault received new equity awards and exercised existing units. On June 24, 2026, she was granted 2,324 restricted stock units and options for 3,691 shares of common stock at an exercise price of $107.55 per share. The options and these RSUs vest in full on the earlier of June 24, 2027 or the day immediately prior to the company’s 2027 annual stockholder meeting, subject to her continued board service.
On June 23, 2026, 4,712 restricted stock units were converted into 4,712 shares of common stock, leaving no remaining units from that grant. Following these transactions, she directly holds 11,712 shares of common stock.
Insider Trade Summary
4,712 shares exercised/converted
Exercise
4 txns
Insider
TETRAULT LYNN A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 3,691 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 2,324 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 4,712 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,712 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 3,691 contracts (Direct);
Restricted Stock Units — 2,324 contracts (Direct);
Common Stock — 11,712 shares (Direct)
Footnotes (4)
- F1. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F2. The restricted stock units are fully vested. The restricted stock units have no expiration date.
- F3. The options fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date.
- F4. The restricted stock units fully vest upon the earlier of (i) June 24, 2027 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2027, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
Key Figures
RSU grant: 2,324 restricted stock units
Option grant size: 3,691 options
Option exercise price: $107.55 per share
+4 more
7 metrics
RSU grant
2,324 restricted stock units
Grant to director on June 24, 2026
Option grant size
3,691 options
Right to buy common stock, granted June 24, 2026
Option exercise price
$107.55 per share
Exercise price for 3,691 stock options
RSUs exercised
4,712 units
Converted into 4,712 common shares on June 23, 2026
Common shares after transactions
11,712 shares
Direct holdings following reported transactions
Option expiration
June 23, 2036
Expiration date of 3,691 stock options
Vesting date trigger
June 24, 2027
Latest vesting date for new RSUs and options
Key Terms
Restricted Stock Units, Stock Option (right to buy), derivative security, vesting, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"The options fully vest upon the earlier of (i) June 24, 2027"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"The restricted stock units have no expiration date."
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did RYTM director Lynn A. Tetreault receive?
Lynn A. Tetreault received 2,324 restricted stock units and stock options for 3,691 shares at an exercise price of $107.55 per share. These awards increase her long-term equity exposure to Rhythm Pharmaceuticals.
When do Lynn A. Tetreault’s new RYTM stock options and RSUs vest?
The new options and restricted stock units fully vest on the earlier of June 24, 2027 or the day immediately before Rhythm Pharmaceuticals’ 2027 annual stockholder meeting, provided Tetreault continues serving as a director through that vesting date.
What happened to the 4,712 restricted stock units reported for RYTM?
The 4,712 restricted stock units were exercised and converted into 4,712 shares of common stock, leaving no remaining units from that specific grant. This conversion increased Tetreault’s direct share ownership in Rhythm Pharmaceuticals.
Do the reported RYTM restricted stock units have an expiration date?
The footnotes state that the restricted stock units have no expiration date. They represent a contingent right to receive one share of Rhythm Pharmaceuticals common stock for each unit, subject to vesting conditions being satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
